Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis.
Writing Committee for the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group; Kempen JH, Altaweel MM, Holbrook JT, Sugar EA, Thorne JE, Jabs DA. Writing Committee for the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group, et al. Among authors: altaweel mm. JAMA. 2017 May 16;317(19):1993-2005. doi: 10.1001/jama.2017.5103. JAMA. 2017. PMID: 28477440 Free PMC article. Clinical Trial.
Morphologic assessment for glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial.
Gangaputra SS, Altaweel MM, Peng Q, Friedman DS, Rao PK, Foster CS, Kim RY, Reed SB, Srivastava SK, Wong IG, Kempen JH; MUST Trial Research Group. Gangaputra SS, et al. Among authors: altaweel mm. Ocul Immunol Inflamm. 2011 Aug;19(4):267-74. doi: 10.3109/09273948.2011.583376. Ocul Immunol Inflamm. 2011. PMID: 21770805 Free PMC article. Clinical Trial.
Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panuveitis: the multicenter uveitis steroid treatment trial.
Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group; Kempen JH, Altaweel MM, Holbrook JT, Jabs DA, Louis TA, Sugar EA, Thorne JE. Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, et al. Among authors: altaweel mm. Ophthalmology. 2011 Oct;118(10):1916-26. doi: 10.1016/j.ophtha.2011.07.027. Epub 2011 Aug 15. Ophthalmology. 2011. PMID: 21840602 Free PMC article. Clinical Trial.
Identifying a clinically meaningful threshold for change in uveitic macular edema evaluated by optical coherence tomography.
Sugar EA, Jabs DA, Altaweel MM, Lightman S, Acharya N, Vitale AT, Thorne JE; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Sugar EA, et al. Among authors: altaweel mm. Am J Ophthalmol. 2011 Dec;152(6):1044-1052.e5. doi: 10.1016/j.ajo.2011.05.028. Epub 2011 Sep 8. Am J Ophthalmol. 2011. PMID: 21861971 Free PMC article. Clinical Trial.
Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial--lessons for comparative effectiveness trials.
Holbrook JT, Kempen JH, Prusakowski NA, Altaweel MM, Jabs DA; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Holbrook JT, et al. Among authors: altaweel mm. Clin Trials. 2011 Dec;8(6):736-43. doi: 10.1177/1740774511423682. Epub 2011 Oct 12. Clin Trials. 2011. PMID: 21994128 Free PMC article. Clinical Trial.
Associations among visual acuity and vision- and health-related quality of life among patients in the multicenter uveitis steroid treatment trial.
Frick KD, Drye LT, Kempen JH, Dunn JP, Holland GN, Latkany P, Rao NA, Sen HN, Sugar EA, Thorne JE, Wang RC, Holbrook JT; Multicenter Uveitis Steroid Treatment-MUST Trial Research Group. Frick KD, et al. Invest Ophthalmol Vis Sci. 2012 Mar 9;53(3):1169-76. doi: 10.1167/iovs.11-8259. Print 2012 Mar. Invest Ophthalmol Vis Sci. 2012. PMID: 22247489 Free PMC article. Clinical Trial.
Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.
Sen HN, Drye LT, Goldstein DA, Larson TA, Merrill PT, Pavan PR, Sheppard JD, Burke A, Srivastava SK, Jabs DA; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Sen HN, et al. Ocul Immunol Inflamm. 2012 Apr;20(2):104-12. doi: 10.3109/09273948.2011.647228. Ocul Immunol Inflamm. 2012. PMID: 22409563 Free PMC article. Clinical Trial.
Optical coherence tomography evaluation in the Multicenter Uveitis Steroid Treatment (MUST) trial.
Domalpally A, Altaweel MM, Kempen JH, Myers D, Davis JL, Foster CS, Latkany P, Srivastava SK, Stawell RJ, Holbrook JT; MUST Trial Research Group. Domalpally A, et al. Among authors: altaweel mm. Ocul Immunol Inflamm. 2012 Dec;20(6):443-7. doi: 10.3109/09273948.2012.719258. Epub 2012 Nov 19. Ocul Immunol Inflamm. 2012. PMID: 23163490 Free PMC article. Clinical Trial.
70 results